دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Percutaneous Coronary Intervention Following Diagnostic Angiography by Noninterventional Versus Interventional Cardiologists: Insights From the CathPCI Registry
Lima, Fabio V. MD, MPH; Manandhar, Pratik MSc; Wojdyla, Daniel MSc; Wang, Tracy MD, MHS, MS; Aronow, Herbert D. MD, MPH; Kadiyala, Vishnu MD; Weissler, E. Hope MD; Madan, Nidhi MD, MPH; Gilchrist, Ian C. MD; Grines, Cindy MD; Abbott, J. Dawn MD
doi : 10.1161/CIRCINTERVENTIONS.121.011086
Volume 15(1), January 2022, p e011086
There are limited contemporary, national data describing diagnostic cardiac catheterization with subsequent percutaneous coronary intervention (ad hoc percutaneous coronary intervention [PCI]) performed by an invasive-diagnostic and interventional (Dx/IC) operator team versus solo interventional operator (solo-IC). Using the CathPCI Registry, this study aimed at analyzing trends and outcomes in ad hoc PCI among Dx/IC versus solo-IC operators.
Long-Term Outcomes in Adult Patients With Pulmonary Hypertension After Percutaneous Closure of Atrial Septal Defects
Akseer, Selai MSc; Abrahamyan, Lusine MD, PhD; Lee, Douglas S. MD, PhD; Huszti, Ella PhD; Meier, Lukas M. MD; Osten, Mark MD; Benson, Lee MD; Horlick, Eric MDCM
doi : 10.1161/CIRCINTERVENTIONS.121.011110
Volume 15(1), January 2022, p e011110
Pulmonary hypertension (PH), recently redefined as mean pulmonary arterial pressure >20 mm Hg (PH20), may be observed in patients with atrial septal defects (ASD). We aimed to determine the effect of preprocedural PH20Â status on outcomes among patients undergoing ASD closure.
Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial
Jones, Thomas K. MD; McElhinney, Doff B. MD; Vincent, Julie A. MD; Hellenbrand, William E. MD; Cheatham, John P. MD; Berman, Darren P. MD; Zahn, Evan M. MD; Khan, Danyal M. MD; Rhodes, John F. Jr MD; Weng, Shicheng MS; Bergersen, Lisa J. MD, MPH
doi : 10.1161/CIRCINTERVENTIONS.121.010852
Volume 15(1), January 2022, p e010852
The Melody valve was developed to extend the useful life of previously implanted right ventricular outflow tract (RVOT) conduits or bioprosthetic pulmonary valves, while preserving RV function and reducing the lifetime burden of surgery for patients with complex congenital heart disease.
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
Cavender, Matthew A. MD, MPH; Harrington, Robert A. MD; Stone, Gregg W. MD; Steg, Ph. Gabriel MD; Gibson, C. Michael MD; Hamm, Christian W. MD; Price, Matthew J. MD; Lopes, Renato D. MD; Leonardi, Sergio MD; Deliargyris, Efthymios N. MD; Prats, Jayne PhD; Mahaffey, Kenneth W. MD; White, Harvey D. DSc; Bhatt, Deepak L. MD, MPH; on behalf of the CHAMPION PHOENIX Investigators
doi : 10.1161/CIRCINTERVENTIONS.120.010390
Volume 15(1), January 2022, p e010390
Thrombotic events are reduced with cangrelor, an intravenous P2Y12Â inhibitor. We sought to characterize the timing, number, and type of early events (within 2 hours of randomization) in CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention).
Percutaneous Coronary Intervention Operator Profiles and Associations With In-Hospital Mortality
Doll, Jacob A. MD; Nelson, Adam J. MBBS, PhD; Kaltenbach, Lisa A. MS; Wojdyla, Daniel MS; Waldo, Stephen W. MD; Rao, Sunil V. MD; Wang, Tracy Y. MD, MSc, MHS
doi : 10.1161/CIRCINTERVENTIONS.121.010909
Volume 15(1), January 2022, p e010909
Percutaneous coronary intervention is performed by operators with differing experience, technique, and case mix. It is unknown if operator practice patterns impact patient outcomes. We sought to determine if a cluster algorithm can identify distinct profiles of percutaneous coronary intervention operators and if these profiles are associated with patient outcomes.
Long-Term Changes in Invasive Physiological Pressure Indices of Stenosis Severity Following Transcatheter Aortic Valve Implantation
Sabbah, Muhammad MD; Joshi, Francis R. MD, PhD; Minkkinen, Mikko MD, PhD; Holmvang, Lene MD, PhD; Tilsted, Hans-Henrik MD, PhD; Pedersen, Frants MD, PhD; Ahtarovski, Kiril MD, PhD; Sorensen, Rikke MD, PhD; Thue Olsen, Niels MD, PhD; Sondergaard, Lars MD, PhD, DMSc; De Backer, Ole MD, PhD; Engstrom, Thomas MD, PhD, DMSc; Lonborg, Jacob MD, PhD, DMSc
doi : 10.1161/CIRCINTERVENTIONS.121.011331
Volume 15(1), January 2022, p e011331
Patients with severe aortic stenosis frequently have coexisting coronary artery disease. Invasive hyperemic and nonhyperemic pressure indices are used to assess coronary artery disease severity but have not been evaluated in the context of severe aortic stenosis.
Is Routine Postdilation During Angiography-Guided Stent Implantation as Good as Intravascular Ultrasound Guidance?: An Analysis Using Data From IVUS-XPL and ULTIMATE
Lee, Yong-Joon MD*,; Zhang, Jun-Jie MD*,; Mintz, Gary S. MD; Hong, Sung-Jin MD; Ahn, Chul-Min MD; Kim, Jung-Sun MD; Kim, Byeong-Keuk MD; Ko, Young-Guk MD; Choi, Donghoon MD; Jang, Yangsoo MD; Kan, Jing MD; Pan, Tao MBS; Gao, Xiaofei MD; Ge, Zhen MD; Chen, Shao-Liang MD; Hong, Myeong-Ki MD
doi : 10.1161/CIRCINTERVENTIONS.121.011366
Volume 15(1), January 2022, p e011366
There are 2 competing approaches to optimize drug-eluting stent implantation: angiography-guided routine postdilation or intravascular ultrasound (IVUS) guidance.
Posting Another Win for Intravascular Imaging: Moving Away From Angiography-Only Percutaneous Coronary Intervention Toward a More Comprehensive Approach
Vora, Amit N. MD, MPH; Swaminathan, Rajesh V. MD
doi : 10.1161/CIRCINTERVENTIONS.121.011670
Volume 15(1), January 2022, p e011670
Racial Disparities in Invasive Management for Patients With Acute Myocardial Infarction With Chronic Kidney Disease
Rymer, Jennifer A. MD, MBA, MHS; Li, Shuang MS; Pun, Patrick H. MD, MHS; Thomas, Laine PhD; Wang, Tracy Y. MD, MHS, MSc
doi : 10.1161/CIRCINTERVENTIONS.121.011171
Volume 15(1), January 2022, p e011171
Due to increased risks of contrast nephropathy, chronic kidney disease (CKD) can deter consideration of invasive management for patients with myocardial infarction (MI). Black patients have a higher prevalence of CKD. Whether racial disparities exist in the use of invasive MI management for patients with CKD presenting with MI is unknown.
Impact of Frailty and Prefrailty on Outcomes of Transcatheter or Surgical Aortic Valve Replacement
Arnold, Suzanne V. MD, MHA; Zhao, Yanglu PhD; Leon, Martin B. MD; Sathananthan, Janar MBChB, MPH; Alu, Maria MS; Thourani, Vinod H. MD; Smith, Craig R. MD; Mack, Michael J. MD; Cohen, David J. MD, MSc
doi : 10.1161/CIRCINTERVENTIONS.121.011375
Volume 15(1), January 2022, p e011375
Randomized trials have shown short- and mid-term benefits with transcatheter versus surgical aortic valve replacement (TAVR versus SAVR) for patients at intermediate or low-risk for surgery. Frailty and prefrailty could explain some of this benefit due to an impaired ability to recover fully from a major surgical procedure.
The Influence of Frailty on Cardiovascular Disease: The Time for a "Frailty Academic Research Consortium" Is Now!
Damluji, Abdulla A. MD, PhD; Cohen, Mauricio G. MD
doi : 10.1161/CIRCINTERVENTIONS.121.011669
Volume 15(1), January 2022, p e011669
Patient-Reported Outcome Measures in Symptomatic, Non-Limb-Threatening Peripheral Artery Disease: A State-of-the-Art Review
Rymer, Jennifer A. MD, MBA, MHS; Narcisse, Dennis MD, MS; Cosiano, Michael MD; Tanaka, John MD; McDermott, Mary M. MD; Treat-Jacobson, Diane J. PhD, RN; Conte, Michael S. MD; Tuttle, Brandi MS; Patel, Manesh R. MD; Smolderen, Kim G. PhD
doi : 10.1161/CIRCINTERVENTIONS.121.011320
Volume 15(1), January 2022, p e011320
Patient-reported outcome measures (PROMs) are health outcomes directly reported by the patient that can be used to measure the effect of disease and treatments on patient perceived well-being. This review summarizes current evidence regarding the validation of PROMs in people with symptomatic, nonlimb-threatening peripheral artery disease. A literature search was conducted to identify studies of symptomatic peripheral artery disease without limb-threatening ischemia that included PROMs and had sample sizes >=25. PROMs were summarized along a continuum of validation using classical test theory framework and according to whether they fulfilled defined criteria for (1) content validity; (2) psychometric validation; and (3) further validation evidence base expansion. Of 2198 articles identified, 157 (7.1%) met inclusion criteria. Twenty-four PROMs in patients with symptomatic peripheral artery disease were reviewed. Among disease-specific PROMs, 8 of 15 had excellent reliability as measured by a Cronbach alpha >=0.80. Based on established criteria for PROM responsiveness, 6 of 15 disease-specific PROMs demonstrated excellent sensitivity to change. Of these, the disease-specific peripheral artery questionnaire, vascular quality of life questionnaire, and walking impairment questionnaire met criteria for validation at each stage of the continuum. For generic (nondisease specific) PROMs, the European Quality of Life 5-Dimension and SF-36 had the most extensive evidence of validation. Evidence from this review can inform selection of PROMs aligned with scientific and clinical goals, given the variable degree of validation and potential complementary nature of the measures.
Impact of Interdisciplinary System-Wide Limb Salvage Advisory Council on Lower Extremity Major Amputation
Shishehbor, Mehdi H. DO, MPH, PhD; Hammad, Tarek A. MD; Rhone, Tonia J. MS; Younes, Ahmad MD; Kumins, Norman MD; Abdullah, Abdullah MD; Li, Jun MD; Harth, Karem MD; Carman, Teresa L. MD; Gornik, Heather L. MD; Pronovost, Peter J. MD, PhD; Kashyap, Vikram S. MD
doi : 10.1161/CIRCINTERVENTIONS.121.011306
Volume 15(1), January 2022, p e011306
Standardized Invasive Hemodynamics for Management of Patients With Elevated Echocardiographic Gradients Post-Transcatheter Aortic Valve Replacement at Midterm Follow-Up
Barker, Madeleine MD; Abbas, Amr E. MD; Webb, John G. MD; Pibarot, Philippe MD; Sathananthan, Janarthanan MBChB, MPH; Brunner, Nathan MD; Wang, Dee Dee MD; Wang, Jia MSc; Leon, Martin B. MD; Wood, David A. MD
doi : 10.1161/CIRCINTERVENTIONS.121.011243
Volume 15(1), January 2022, p e011243
Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension
Anderson, Jason H. MD; Cabalka, Allison K. MD; Frantz, Robert P. MD; Cajigas, Hector R. MD; Taggart, Nathaniel W. MD
doi : 10.1161/CIRCINTERVENTIONS.121.011315
Volume 15(1), January 2022, p e011315
Letter by Le Ruz and Manigold Regarding Article, "Compared Outcomes ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER MI Trial"
Le Ruz, Robin MD; Manigold, Thibaut MD
doi : 10.1161/CIRCINTERVENTIONS.121.011587
Volume 15(1), January 2022, p e011587
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER MI Trial"
Puymirat, Etienne MD, PhD; Danchin, Nicolas MD
doi : 10.1161/CIRCINTERVENTIONS.121.011614
Volume 15(1), January 2022, p e011614
Letter by Cerrato and Escaned Regarding Article, "Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial"
Cerrato, Enrico MD, PhD; Escaned, Javier MD, PhD
doi : 10.1161/CIRCINTERVENTIONS.121.011497
Volume 15(1), January 2022, p e011497
Response by Puymirat and Danchin to Letter Regarding Article, "Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial"
Puymirat, Etienne MD, PhD; Danchin, Nicolas MD
doi : 10.1161/CIRCINTERVENTIONS.121.011667
Volume 15(1), January 2022, p e011667
